Trials / Unknown
UnknownNCT03232242
Application of NGS Technique in Precise Diagnosis of Infectious Diseases
Application of Next Generation Sequencing Technique in Precise Diagnosis of Infectious Diseases
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Huashan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Infectious disease leads to deaths that accounted for more than 25% of all causes of human mortality. But the traditional microbiological diagnostic methods such as specimen culture are sometimes time-consuming, and have limited sensitivity. And some bacteria, anaerobes and viruses may be difficult to cultivate and isolation. Therefore, the accurate identification and rapid classification of pathogenic microorganisms is very important for the patient's precise diagnosis and timely treatment. Small-scale studies on the diagnostic efficacy and prognosis of infection in the next generation have been shown to provide early diagnosis and targeted medication guidance for bloodstream infections and respiratory infections, but the larger-scale validation of next-generation sequencing Technology in the diagnosis and treatment of infectious diseases in the human body is relatively rare. The purpose of this study is to provide rapid etiological diagnosis of patients by means of next-generation sequencing, to change the way of treatment of patients under the existing traditional pathogen detection by means of accurate description of pathogens and monitoring their dynamic changes, and to provide patients with more accurate treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Next-generation sequencing | To provide rapid etiological diagnosis of patients by means of next-generation sequencing. |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2020-07-31
- Completion
- 2020-12-31
- First posted
- 2017-07-27
- Last updated
- 2017-07-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03232242. Inclusion in this directory is not an endorsement.